Ironwood Pharmaceuticals (IRWD) Stock Forecast & Price Target

$3.44 +0.10 (+2.99%)

(As of 11/22/2024 ET)

Ironwood Pharmaceuticals - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 6 Analyst Ratings

Sell
0

Hold
3

Buy
3

Based on 6 Wall Street analysts who have issued ratings for Ironwood Pharmaceuticals in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 6 analysts, 3 have given a hold rating, and 3 have given a buy rating for IRWD.

Consensus Price Target

$10.40
202.33% Upside

According to the 6 analysts' twelve-month price targets for Ironwood Pharmaceuticals, the average price target is $10.40. The highest price target for IRWD is $21.00, while the lowest price target for IRWD is $4.00. The average price target represents a forecasted upside of 202.33% from the current price of $3.44.

Get the Latest News and Ratings for IRWD and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ironwood Pharmaceuticals and its competitors.

IRWD Analyst Ratings Over Time

Type	Current Forecast 11/25/23 to 11/24/24	1 Month Ago 10/26/23 to 10/25/24	3 Months Ago 8/27/23 to 8/26/24	1 Year Ago 11/25/22 to 11/25/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	4 Buy rating(s)	5 Buy rating(s)	2 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$10.40	$12.17	$15.00	$20.67
Forecasted Upside	202.33% Upside	207.24% Upside	197.62% Upside	115.05% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy

Former Trump advisor releases terrifying warning (Ad)

Goldman Sachs: 300 Million People Are At Risk The mainstream media are practically ignoring the most important financial story of the decade. Goldman Sachs, the IMF, JP Morgan, Bank of America, and Morgan Stanley have issued warnings. Yet most ordinary Americans have no idea. Now one former Trump advisor is sounding the alarm. “If people knew the full facts, there’d be blood in the streets.”

Get the facts and learn how to protect your family now.

IRWD Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

IRWD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Ironwood Pharmaceuticals Stock vs. The Competition

Type	Ironwood Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	2.50	2.80	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	202.33% Upside	27,073.48% Upside	7.66% Upside
News Sentiment Rating	Neutral News See Recent IRWD News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/9/2024	Leerink Partnrs 5 of 5 stars	F. Khurshid Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
9/9/2024	Leerink Partners 1 of 5 stars		Initiated Coverage	Market Perform	$5.00	+10.86%
8/9/2024	Wells Fargo & Company 3 of 5 stars		Lower Target	Overweight ➝ Overweight	$14.00 ➝ $12.00	+183.02%
8/9/2024	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$14.00 ➝ $10.00	+134.74%
8/8/2024	Capital One Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Chiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$12.00 ➝ $4.00	+3.36%
2/16/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$20.00 ➝ $21.00	+41.22%
11/9/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$21.00	+127.52%
9/28/2023	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$22.00	+128.45%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 09:21 PM ET.

IRWD Forecast - Frequently Asked Questions

: According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Ironwood Pharmaceuticals is $10.40, with a high forecast of $21.00 and a low forecast of $4.00.
: 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ironwood Pharmaceuticals in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" IRWD shares.
: According to analysts, Ironwood Pharmaceuticals's stock has a predicted upside of 202.33% based on their 12-month stock forecasts.
: Over the previous 90 days, Ironwood Pharmaceuticals's stock had 1 upgrade by analysts.
: Ironwood Pharmaceuticals has been rated by research analysts at Leerink Partners, and Leerink Partnrs in the past 90 days.
: Analysts like Ironwood Pharmaceuticals less than other "medical" companies. The consensus rating score for Ironwood Pharmaceuticals is 2.50 while the average consensus rating score for "medical" companies is 2.80. Learn more on how IRWD compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Former Trump advisor releases terrifying warning (Ad)

Get the facts and learn how to protect your family now.

This page (NASDAQ:IRWD) was last updated on 11/24/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ironwood Pharmaceuticals (IRWD) Stock Forecast & Price Target